Skip to main content
SURGICAL INNOVATIONS GROUP PLC logo

SURGICAL INNOVATIONS GROUP PLC — Investor Relations & Filings

Ticker · SUN ISIN · GB0004016704 LEI · 2138004GHGUH3HUZE156 IL Manufacturing
Filings indexed 277 across all filing types
Latest filing 2023-05-25 Director's Dealing
Country GB United Kingdom
Listing IL SUN

About SURGICAL INNOVATIONS GROUP PLC

https://www.surgicalinnovations.com/

Surgical Innovations Group PLC designs, develops, manufactures, and distributes medical devices for minimally invasive surgery (MIS). The company specializes in creating sustainable and innovative solutions that aim to reduce the environmental impact of surgical procedures. A core part of its portfolio is the "Resposable®" technology, which integrates reusable and disposable components to offer clinically effective and environmentally conscious alternatives to single-use instruments. In addition to its branded products, the group provides original equipment manufacturing (OEM) services, engineering, and manufacturing for other medical device companies. The focus is on providing high-quality, accessible products for healthcare professionals performing keyhole surgery.

Recent filings

Filing Released Lang Actions
Director/PDMR Shareholding
Director's Dealing Classification · 99% confidence The document is titled 'Director/PDMR Shareholding' and details the purchase of ordinary shares by the wife of a Non-executive Director (Jonathan Glenn). It explicitly lists the transaction details, including price and volume, and is filed under an RNS Number (5813A) from the London Stock Exchange. This content directly corresponds to the reporting of personal share transactions by company directors and executives, which matches the definition for Director's Dealing (DIRS).
2023-05-25 English
Directorate changes and board succession planning
Board/Management Information Classification · 99% confidence The document is an official announcement released via RNS (RNS Number : 1108A) from Surgical Innovations Group PLC. The core content announces 'Directorate changes and board succession planning,' specifically the appointment of a new Senior Independent Non-executive Director and Chairman-designate, and the upcoming retirement of the current Chairman. This directly relates to changes in senior management and the board of directors. This aligns perfectly with the definition for Board/Management Information (MANG). It is not a full financial report (10-K, IR), an earnings release (ER), or a proxy statement (DEF 14A/PSI).
2023-05-22 English
Group of companies' accounts made up to 2022-12-31
Regulatory Filings
2023-05-09 English
Final Results
Earnings Release Classification · 95% confidence The document is an 'Earnings Release' (ER) because it is an initial announcement of financial results for the year ended 31 December 2022. It contains key financial highlights (revenue, EBITDA, EPS), operational updates, and management commentary. While it mentions 'Audited results', it is structured as an RNS announcement (Regulatory News Service) providing a summary of the performance rather than the full, multi-hundred-page Annual Report (10-K). It does not meet the criteria for a report publication announcement (RPA) because it contains substantive financial data and analysis rather than just a link to a report. FY 2022
2023-03-29 English
Notice of Results and Investor Presentation
Report Publication Announcement Classification · 99% confidence The document is an RNS announcement (indicated by 'RNS Number : 7242R' and the closing statement referencing RNS/LSE). The core content is a 'Notice of results' and 'Investor presentation' announcement, stating that the company will release its audited results on a future date (March 29, 2023) and will host a live presentation via the Investor Meet Company platform. This is not the actual results report (ER or IR) or the presentation itself, but rather an announcement about the upcoming release and presentation. According to Rule 2, when a document announces the publication or timing of a report/event, it should be classified as a Report Publication Announcement (RPA).
2023-03-03 English
Year-end Trading Update
Earnings Release Classification · 100% confidence The document is titled 'Year-end Trading Update' and provides unaudited financial highlights (Revenues, Gross Margin, Adjusted EBITDA) for the year ended 31 December 2022. It discusses sales performance, outlook, and cash position. This content strongly suggests an announcement of preliminary financial results for a period, which aligns best with an Earnings Release (ER). Although it covers a full year, it is explicitly labeled as a 'Trading Update' and provides summary figures rather than the comprehensive detail expected in a full 10-K. The document is distributed via RNS, which is a general regulatory news service, but the content itself is a specific financial announcement. FY 2022
2023-01-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.